Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724333 | SCV000227255 | uncertain significance | not provided | 2014-11-10 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001084650 | SCV000349841 | uncertain significance | EAST syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Illumina Laboratory Services, |
RCV000348162 | SCV000349842 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Invitae | RCV001084650 | SCV000552193 | likely benign | EAST syndrome | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724333 | SCV000616991 | uncertain significance | not provided | 2023-06-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Center for Genomics, |
RCV000768246 | SCV000898773 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 4; EAST syndrome | 2021-11-01 | criteria provided, single submitter | clinical testing | KCNJ10 NM_002241 exon 2 p.Glu177Gly (c.530A>G): This variant has not been reported in the literature but is present in 0.7% (50/6682) of Ashkenazi Jewish alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs145947380). This variant is present in ClinVar (Variation ID: 195165). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV000724333 | SCV001248565 | uncertain significance | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345601 | SCV002644930 | benign | Inborn genetic diseases | 2024-02-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004537388 | SCV004741133 | likely benign | KCNJ10-related disorder | 2023-02-17 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |